ZA753316B - Method and composition for treating schizophrenia - Google Patents

Method and composition for treating schizophrenia

Info

Publication number
ZA753316B
ZA753316B ZA00753316A ZA753316A ZA753316B ZA 753316 B ZA753316 B ZA 753316B ZA 00753316 A ZA00753316 A ZA 00753316A ZA 753316 A ZA753316 A ZA 753316A ZA 753316 B ZA753316 B ZA 753316B
Authority
ZA
South Africa
Prior art keywords
composition
treating schizophrenia
schizophrenia
treating
Prior art date
Application number
ZA00753316A
Other languages
English (en)
Inventor
K Fuxe
Original Assignee
Nelson Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nelson Res & Dev filed Critical Nelson Res & Dev
Publication of ZA753316B publication Critical patent/ZA753316B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ZA00753316A 1974-06-03 1975-05-22 Method and composition for treating schizophrenia ZA753316B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/475,856 US3947579A (en) 1974-06-03 1974-06-03 Method and composition for potentiating neuroleptic drugs

Publications (1)

Publication Number Publication Date
ZA753316B true ZA753316B (en) 1976-04-28

Family

ID=23889440

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00753316A ZA753316B (en) 1974-06-03 1975-05-22 Method and composition for treating schizophrenia

Country Status (12)

Country Link
US (1) US3947579A (fr)
AU (1) AU499034B2 (fr)
BE (1) BE829830A (fr)
CA (1) CA1048932A (fr)
DE (1) DE2523998A1 (fr)
FR (1) FR2272646B1 (fr)
GB (2) GB1514311A (fr)
IE (1) IE41374B1 (fr)
IL (1) IL47324A (fr)
NL (1) NL7506404A (fr)
PH (1) PH13894A (fr)
ZA (1) ZA753316B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453643A2 (fr) * 1977-06-24 1980-11-07 Synthelabo Compositions pharmaceutiques actives sur le systeme nerveux central
US4160835A (en) * 1976-11-19 1979-07-10 Merck & Co., Inc. Antihypertensive compositions containing an arylsubstituted alanine and a phenyl hydrazinopropionic acid
NL7706429A (nl) * 1977-06-10 1978-12-12 Univ Erasmus Werkwijze voor de bereiding van een geneesmid- del met angst en angstequivalenten opheffende werking en gevormd geneesmiddel met een derge- lijke werking.
US4148896A (en) * 1978-02-22 1979-04-10 E. I. Du Pont De Nemours And Company Antidepressant combination
US4346085A (en) * 1980-02-29 1982-08-24 Massachusetts Institute Of Technology Process and composition for treating disorders by administering amphetamine and choline
NL8006135A (nl) * 1980-11-10 1982-06-01 Univ Erasmus Geneesmiddel met angst en angstequivalenten opheffende werking en werkwijze voor de bereiding van een dergelijk geneesmiddel.
US4636494A (en) * 1981-01-30 1987-01-13 Massachusetts Institute Of Technology Process and composition for treating disorders by administering amphetamine and choline
DK373383A (da) 1982-08-20 1984-02-21 Midit Fremgangsmaade til fremstilling af omega-aminosyrederivater
US5296277A (en) * 1992-06-26 1994-03-22 Minnesota Mining And Manufacturing Company Positionable and repositionable adhesive articles
US5637617A (en) * 1994-04-01 1997-06-10 The Regents Of The University Of California Methods for use of GABAa receptor GABAergic compounds
US20050192220A1 (en) * 2001-02-05 2005-09-01 Gevys Pharmaceuticas Ltd. Composition and method for potentiating drugs
US6833377B2 (en) 2001-02-05 2004-12-21 Gevys Pharmaceuticals Ltd. Composition and method for potentiating drugs
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
ES2379544T3 (es) 2001-09-27 2012-04-27 Ramot At Tel Aviv University Ltd. Conjugado de perfenazina y GABA y usos del mismo
EP2272537A3 (fr) * 2005-06-07 2014-10-22 Ramot at Tel-Aviv University Ltd. Sels de conjuguées de médicaments psychotropiques et procédés pour leur synthèse
CA2610838A1 (fr) * 2005-06-07 2006-12-14 Ramot At Tel Aviv University Ltd. Nouveaux sels de medicaments psychotropes conjugues et leurs procedes de preparation
WO2008010223A2 (fr) 2006-07-17 2008-01-24 Ramot At Tel Aviv University Ltd. Conjugués de gaba anti-douleur
US8207369B2 (en) 2008-02-11 2012-06-26 Ramot At Tel-Aviv University Ltd. Conjugates for treating neurodegenerative diseases and disorders
EP2291181B9 (fr) 2008-04-18 2013-09-11 University College Dublin National University Of Ireland, Dublin Utilisation de la captodiamine pour le traitement des symptômes de la dépression
EP2509603A1 (fr) 2009-12-09 2012-10-17 Biolinerx Ltd. Procédés d'amélioration des fonctions cognitives
WO2012038963A1 (fr) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. Sel d'addition d'acide d'un conjugué nortriptyline-gaba et son procédé de préparation
WO2016176609A1 (fr) 2015-04-30 2016-11-03 Ovid Therapeutics Inc Procédés de traitement du syndrome de prader-willi
US9351968B1 (en) 2015-09-09 2016-05-31 Ovid Therapeutics Inc Methods of treating developmental disorders using pipradrol
WO2017205606A1 (fr) 2016-05-26 2017-11-30 Ovid Therapeutics Inc. Procédés de traitement de syndromes du comportement à l'aide de pipradrol
US10071083B2 (en) 2017-02-03 2018-09-11 Ovid Therapeutics Inc Use of gaboxadol in the treatment of tinnitus

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH449645A (de) * 1963-07-09 1968-01-15 Ciba Geigy Verfahren zur Herstellung neuer Aminosäuren
US3505451A (en) * 1967-08-14 1970-04-07 Geigy Chem Corp Compositions and methods for alleviating schizophrenia employing one of haloperidol,trifluperidol or an acid addition salt thereof and one of desipramine,imipramine and an acid addition salt thereof

Also Published As

Publication number Publication date
IE41374B1 (en) 1979-12-19
FR2272646A1 (fr) 1975-12-26
DE2523998A1 (de) 1975-12-11
US3947579A (en) 1976-03-30
GB1514312A (en) 1978-06-14
FR2272646B1 (fr) 1978-11-10
NL7506404A (nl) 1975-12-05
BE829830A (fr) 1975-10-01
PH13894A (en) 1980-10-27
IL47324A (en) 1979-03-12
AU8143875A (en) 1976-11-25
IE41374L (en) 1975-12-03
CA1048932A (fr) 1979-02-20
GB1514311A (en) 1978-06-14
IL47324A0 (en) 1975-08-31
AU499034B2 (en) 1979-04-05

Similar Documents

Publication Publication Date Title
ZA753316B (en) Method and composition for treating schizophrenia
JPS5223064A (en) Composition and method
JPS5254093A (en) Material composition and method
ZA755287B (en) Crotch-shaped diaper and method
ZA747054B (en) Composition and method for treating scours
JPS5212759A (en) Method of treating waste
JPS5296776A (en) Method and composition for preventing nutrition shortage
JPS52148610A (en) Method and apparatus for filterrsterilized blooddagglutination composition
JPS528681A (en) Apparatus for treating wasted material and method thereof
JPS51132369A (en) Limit stopping method and apparatus
JPS5210243A (en) Compositions and process
IL47368A (en) Method and apparatus for immunodiffusion
JPS5248647A (en) Compositions and process
ZA767170B (en) Detergent composition and method for use
JPS5486605A (en) Erythromicine treating method
CA1017245A (fr) Controle du limon
ZA764766B (en) Dyeing process and compositions for use therein
IL48640A (en) 1-alkyl-2-(phenoxymethyl)-5-nitro-imidazoles and process for their manufacture
JPS5253093A (en) Cloth condisioning method and composition
JPS53103497A (en) Heterocyclopyrimidines composition and treating method
ZA75392B (en) Process and composition for the control of helminths
GB1538761A (en) Method for starting and stopping spinning positions
MY8300083A (en) Composition and method for treating hair
JPS521198A (en) Molding and treating apparatus for and method for cloth
ZA756563B (en) Method for the treatment of gingivitis